STOCK TITAN

Hinge Health CFO James Budge sells 35,907 shares

Available on EDGAR Accepted by SEC EDGAR Learn about SEC filing dates
(Neutral)

Sentiment and the balance of points

Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.

Form Type
4

Rhea-AI Filing Summary

Hinge Health, Inc. (HNGE) Chief Financial Officer James Budge reported direct sales of 35,907 Class A common shares on November 10, 2026, in five tranches: 1,900 at a weighted average price of $119.5214 per share, 7,601 at $120.6851, 15,899 at $121.3642, 4,925 at $122.7538, and 5,582 at $123.3433. The sales were made under a Rule 10b5-1 trading plan adopted June 11, 2026.

Insider Budge James
Role Chief Financial Officer
Sold 35,907 shs ($4.37M)
Type Security Shares Price Value
Sale Class A Common Stock F1, F2 1,900 $119.5214 $227K
Sale Class A Common Stock F1, F3 7,601 $120.6851 $917K
Sale Class A Common Stock F1, F4 15,899 $121.3642 $1.93M
Sale Class A Common Stock F1, F5 4,925 $122.7538 $605K
Sale Class A Common Stock F1, F6 5,582 $123.3433 $689K
Holdings After Transaction: Class A Common Stock — 256,207 shares (Direct)
Footnotes (6)
  1. F1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
  2. F2. Represents the weighted average sale price. The lowest price at which shares were sold was $119.00 and the highest price at which shares were sold was $119.92. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
  3. F3. Represents the weighted average sale price. The lowest price at which shares were sold was $120.05 and the highest price at which shares were sold was $121.04. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
  4. F4. Represents the weighted average sale price. The lowest price at which shares were sold was $121.05 and the highest price at which shares were sold was $122.00. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
  5. F5. Represents the weighted average sale price. The lowest price at which shares were sold was $122.11 and the highest price at which shares were sold was $123.10. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
  6. F6. Represents the weighted average sale price. The lowest price at which shares were sold was $123.11 and the highest price at which shares were sold was $123.77. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
Shares sold 35,907 shares Five direct Class A common stock sales on November 10, 2026.
Sale tranche 1,900 shares at $119.5214 per share Weighted average sale price; November 10, 2026.
Sale tranche 7,601 shares at $120.6851 per share Weighted average sale price; November 10, 2026.
Sale tranche 15,899 shares at $121.3642 per share Weighted average sale price; November 10, 2026.
Sale tranche 4,925 shares at $122.7538 per share Weighted average sale price; November 10, 2026.
Sale tranche 5,582 shares at $123.3433 per share Weighted average sale price; November 10, 2026.
Rule 10b5-1 trading plan regulatory
"effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person"
A Rule 10b5-1 trading plan is a pre-arranged schedule that allows company insiders to buy or sell stock at specific times, even if they have inside information. It helps prevent accusations of unfair trading by making these transactions look planned and transparent, rather than sneaky or illegal.
weighted average sale price financial
"Represents the weighted average sale price"

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How many HNGE shares did CFO James Budge sell, and at what prices?

James Budge sold 35,907 Hinge Health Class A common shares on November 10, 2026, across five tranches: 1,900 at $119.5214, 7,601 at $120.6851, 15,899 at $121.3642, 4,925 at $122.7538, and 5,582 at $123.3433 per share. The sales were made under a Rule 10b5-1 plan adopted June 11, 2026.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
SEC Form 4
FORM 4UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0287
Estimated average burden
hours per response:0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
X
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Budge James

(Last)(First)(Middle)
C/O HINGE HEALTH, INC.
455 MARKET STREET, SUITE 700

(Street)
SAN FRANCISCO CALIFORNIA 94105

(City)(State)(Zip)

UNITED STATES

(Country)
2. Issuer Name and Ticker or Trading Symbol
Hinge Health, Inc. [ HNGE ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
Chief Financial Officer
2a. Foreign Trading Symbol
3. Date of Earliest Transaction (Month/Day/Year)
11/10/2026
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year)2A. Deemed Execution Date, if any (Month/Day/Year)3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeVAmount(A) or (D)Price
Class A Common Stock11/10/2026S(1)1,900D$119.5214(2)290,214D
Class A Common Stock11/10/2026S(1)7,601D$120.6851(3)282,613D
Class A Common Stock11/10/2026S(1)15,899D$121.3642(4)266,714D
Class A Common Stock11/10/2026S(1)4,925D$122.7538(5)261,789D
Class A Common Stock11/10/2026S(1)5,582D$123.3433(6)256,207D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year)3A. Deemed Execution Date, if any (Month/Day/Year)4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year)7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
CodeV(A)(D)Date ExercisableExpiration DateTitleAmount or Number of Shares
Explanation of Responses:
1. The sales reported in this line item were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 11, 2026.
2. Represents the weighted average sale price. The lowest price at which shares were sold was $119.00 and the highest price at which shares were sold was $119.92. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
3. Represents the weighted average sale price. The lowest price at which shares were sold was $120.05 and the highest price at which shares were sold was $121.04. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
4. Represents the weighted average sale price. The lowest price at which shares were sold was $121.05 and the highest price at which shares were sold was $122.00. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
5. Represents the weighted average sale price. The lowest price at which shares were sold was $122.11 and the highest price at which shares were sold was $123.10. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
6. Represents the weighted average sale price. The lowest price at which shares were sold was $123.11 and the highest price at which shares were sold was $123.77. The Reporting Person undertakes to provide upon request to the staff of the Securities and Exchange Commission, the Issuer or its stockholders, full information regarding the total number of shares sold at each separate price within the range set forth herein.
/s/ James Budge11/12/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Keep reading